Table 2 Adjusted odds ratios for receipt of concurrent CRT versus any other treatment ^a

 Female

0.64

0.40

1.03

White

1.24

1.004

1.53

 Hispanic

0.71

0.39

1.31

 Married

1.13

0.96

1.33

 Medicare enrollment any time between 2013 and 2017

1.13

0.89

1.43

 Medicaid-eligible

0.63

0.34

1.14

 Service connected ≥50%

1.12

0.94

1.33

 Service connected < 50%

1.01

0.81

1.27

Urban residence

1.09

0.91

1.33

 Adenocarcinoma

0.91

0.77

1.07

 Other

0.80

0.62

1.02

 Current smoker

1.41

0.90

2.20

 Former smoker

1.34

0.85

2.10

 Unknown

1.13

0.65

1.95

 2017

1.65

1.27

2.16

 2016

1.36

1.06

1.76

 2015

1.11

0.88

1.39

 2014

1.22

0.98

1.53

Age (increment = 10)

0.67

0.60

0.76

Charlson-Deyo comorbidity score (increment = 1)

0.94

0.91

0.97

Distance between patient residence and medical center based on zip code (increment = 100 miles)

0.95

0.84

1.08

  Northeast

1.01

0.66

1.55

  Midwest

1.19

0.82

1.73

  West

0.89

0.60

1.33

Medical Center Certified by Commission on Cancer

0.93

0.68

1.27

Total number of unique patients seen at oncology clinics at medical center of diagnosis during diagnosis year (increment = 100)

1.03

0.92

1.15

Total number of oncologists at medical center of diagnosis (increment = 10)

0.93

0.70

1.22